Trial Profile
Regional Patterns of Tocilizumab use, Efficacy, and Safety in Patients with Rheumatoid Arthritis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2015
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 28 Jul 2015 New trial record
- 13 Jun 2015 Interim results after 6 months' treatment in 1257 patients who received their first dose by 31 Jan 2014 presented at the 16th Annual Congress of the European League Against Rheumatism.